Brief: Matinas BioPharma Reports Third Quarter 2021 Financial Results And Operational Highlights
08/11/2021 11:38
Nov 8 (Reuters) - Matinas BioPharma Holdings Inc MTNB.A :
* MATINAS BIOPHARMA REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS
AND OPERATIONAL HIGHLIGHTS
* Q3 LOSS PER SHARE $0.03
* BELIEVES CASH ON HAND IS SUFFICIENT TO FUND PLANNED
OPERATIONS
INTO 2024
* Q3 EARNINGS PER SHARE VIEW $-0.02 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX3R93xx
Further company coverage: MTNB.A
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Matinas BioPharma Holdings
See all newsBrief: GH Power Signs Multi-Year Hydrogen Offtake Agreement With Change Energy For Hamilton Facility Output
Brief: Gh Power And Tkms Continue To Explore Clean Energy Collaboration In Support Of Canada’S Future Patrol Submarine Project
Brief: Matinas Biopharma - Btig Terminates Sales Agreement With Matinas Biopharma Holdings, Effective Immediately On July 23, 2026 - SEC Filing
Brief: Matinas Biopharma Receives Notice Of Non-Compliance With NYSE American Continued Listing Standards And Acceptance Of Plan To Regain Compliance
Brief: Matinas Biopharma - May Offer Securities Up To $150 Million - SEC Filing